126 related articles for article (PubMed ID: 35948494)
21. Inhibition of glioblastoma tumorspheres by combined treatment with 2-deoxyglucose and metformin.
Kim EH; Lee JH; Oh Y; Koh I; Shim JK; Park J; Choi J; Yun M; Jeon JY; Huh YM; Chang JH; Kim SH; Kim KS; Cheong JH; Kim P; Kang SG
Neuro Oncol; 2017 Feb; 19(2):197-207. PubMed ID: 27571886
[TBL] [Abstract][Full Text] [Related]
22. Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis.
Cui X; Morales RT; Qian W; Wang H; Gagner JP; Dolgalev I; Placantonakis D; Zagzag D; Cimmino L; Snuderl M; Lam RHW; Chen W
Biomaterials; 2018 Apr; 161():164-178. PubMed ID: 29421553
[TBL] [Abstract][Full Text] [Related]
23. Metformin Reprograms Tryptophan Metabolism to Stimulate CD8+ T-cell Function in Colorectal Cancer.
Huang X; Sun T; Wang J; Hong X; Chen H; Yan T; Zhou C; Sun D; Yang C; Yu T; Su W; Du W; Xiong H
Cancer Res; 2023 Jul; 83(14):2358-2371. PubMed ID: 37195082
[TBL] [Abstract][Full Text] [Related]
24. Hyaluronic acid-functionalized gelatin hydrogels reveal extracellular matrix signals temper the efficacy of erlotinib against patient-derived glioblastoma specimens.
Pedron S; Wolter GL; Chen JE; Laken SE; Sarkaria JN; Harley BAC
Biomaterials; 2019 Oct; 219():119371. PubMed ID: 31352310
[TBL] [Abstract][Full Text] [Related]
25. Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial.
Wang S; Lin Y; Xiong X; Wang L; Guo Y; Chen Y; Chen S; Wang G; Lin P; Chen H; Yeung SJ; Bremer E; Zhang H
Clin Cancer Res; 2020 Sep; 26(18):4921-4932. PubMed ID: 32646922
[TBL] [Abstract][Full Text] [Related]
26. Metformin reprograms tumor microenvironment and boosts chemoimmunotherapy in colorectal cancer.
Ni W; Wu J; Feng Y; Hu Y; Liu H; Chen J; Chen F; Tian H
Biomater Sci; 2022 Sep; 10(19):5596-5607. PubMed ID: 35979933
[TBL] [Abstract][Full Text] [Related]
27. Engineered Macrophage-Membrane-Coated Nanoparticles with Enhanced PD-1 Expression Induce Immunomodulation for a Synergistic and Targeted Antiglioblastoma Activity.
Yin T; Fan Q; Hu F; Ma X; Yin Y; Wang B; Kuang L; Hu X; Xu B; Wang Y
Nano Lett; 2022 Aug; 22(16):6606-6614. PubMed ID: 35948420
[TBL] [Abstract][Full Text] [Related]
28. Local Targeting of NAD
Li M; Kirtane AR; Kiyokawa J; Nagashima H; Lopes A; Tirmizi ZA; Lee CK; Traverso G; Cahill DP; Wakimoto H
Cancer Res; 2020 Nov; 80(22):5024-5034. PubMed ID: 32998997
[TBL] [Abstract][Full Text] [Related]
29. The Influence of Hyaluronic Acid and Glioblastoma Cell Coculture on the Formation of Endothelial Cell Networks in Gelatin Hydrogels.
Ngo MT; Harley BA
Adv Healthc Mater; 2017 Nov; 6(22):. PubMed ID: 28941173
[TBL] [Abstract][Full Text] [Related]
30. Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma.
Zhang H; Zhou Y; Cui B; Liu Z; Shen H
Biomed Pharmacother; 2020 Jun; 126():110086. PubMed ID: 32172060
[TBL] [Abstract][Full Text] [Related]
31. Molecular profiling of the tumor microenvironment in glioblastoma patients: correlation of microglia/macrophage polarization state with metalloprotease expression profiles and survival.
Gjorgjevski M; Hannen R; Carl B; Li Y; Landmann E; Buchholz M; Bartsch JW; Nimsky C
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142630
[TBL] [Abstract][Full Text] [Related]
32. Gelatin Methacryloyl Hydrogels in the Absence of a Crosslinker as 3D Glioblastoma Multiforme (GBM)-Mimetic Microenvironment.
Erkoc P; Seker F; Bagci-Onder T; Kizilel S
Macromol Biosci; 2018 Mar; 18(3):. PubMed ID: 29333657
[TBL] [Abstract][Full Text] [Related]
33.
Shi Y; Jiang J; Cui Y; Chen Y; Dong T; An H; Liu P
DNA Cell Biol; 2021 Jan; 40(1):93-100. PubMed ID: 33181035
[TBL] [Abstract][Full Text] [Related]
34. A Micro-Environment Regulator for Filling the Clinical Treatment Gap after a Glioblastoma Operation.
Zhang Y; You H; Wang Y; Chen Q; Guo Q; Chu Y; Li C; Zhou W; Chen H; Liu P; Wang Y; Zhao Z; Zhou Z; Luo Y; Li X; Zhang T; Song H; Li C; Su B; Sun T; Bi Y; Yu L; Jiang C
Adv Healthc Mater; 2022 Feb; 11(3):e2101578. PubMed ID: 34800085
[TBL] [Abstract][Full Text] [Related]
35. Exploring the Mechanism of Adjuvant Treatment of Glioblastoma Using Temozolomide and Metformin.
Feng SW; Chang PC; Chen HY; Hueng DY; Li YF; Huang SM
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897747
[TBL] [Abstract][Full Text] [Related]
36. Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment.
Jeanmougin M; Håvik AB; Cekaite L; Brandal P; Sveen A; Meling TR; Ågesen TH; Scheie D; Heim S; Lothe RA; Lind GE
Mol Oncol; 2020 May; 14(5):1016-1027. PubMed ID: 32171051
[TBL] [Abstract][Full Text] [Related]
37. EZH2 suppression in glioblastoma shifts microglia toward M1 phenotype in tumor microenvironment.
Yin Y; Qiu S; Li X; Huang B; Xu Y; Peng Y
J Neuroinflammation; 2017 Nov; 14(1):220. PubMed ID: 29132376
[TBL] [Abstract][Full Text] [Related]
38. A comparative study of brain tumor cells from different age and anatomical locations using 3D biomimetic hydrogels.
Wang C; Sinha S; Jiang X; Fitch S; Wilson C; Caretti V; Ponnuswami A; Monje M; Grant G; Yang F
Acta Biomater; 2020 Oct; 116():201-208. PubMed ID: 32911104
[TBL] [Abstract][Full Text] [Related]
39. High-Dose Metformin Plus Temozolomide Shows Increased Anti-tumor Effects in Glioblastoma In Vitro and In Vivo Compared with Monotherapy.
Lee JE; Lim JH; Hong YK; Yang SH
Cancer Res Treat; 2018 Oct; 50(4):1331-1342. PubMed ID: 29334602
[TBL] [Abstract][Full Text] [Related]
40. Clostridium novyi-NT can cause regression of orthotopically implanted glioblastomas in rats.
Staedtke V; Bai RY; Sun W; Huang J; Kibler KK; Tyler BM; Gallia GL; Kinzler K; Vogelstein B; Zhou S; Riggins GJ
Oncotarget; 2015 Mar; 6(8):5536-46. PubMed ID: 25849940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
